Cellectar Biosciences Inc (CLRB)
3.33
-0.03
(-0.89%)
USD |
NASDAQ |
May 16, 16:00
3.33
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.0349M |
| March 31, 2021 | |
| December 31, 2020 | -41.46M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -18.26M |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -9.025M |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -9.076M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | -4.906M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -4.992M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -7.371M |
| March 31, 2016 | |
| December 31, 2015 | -3.30M |
| Date | Value |
|---|---|
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -12.40M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | -4.975M |
| December 31, 2012 | -1.968M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -4.871M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -5.298M |
| September 30, 2011 | 0.00 |
| June 30, 2011 | -4.866M |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | |
| December 31, 2009 | -5.490M |
| September 30, 2009 | -3.449M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-41.46M
Minimum
Dec 2020
--
Maximum
Sep 2019
-7.642M
Average
--
Median
Sep 2019
Stock Buybacks (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -0.364M |
| Eli Lilly and Co | 0.00 |
| Actinium Pharmaceuticals Inc | -14.70M |
| Bristol-Myers Squibb Co | 0.00 |
| Altimmune Inc | -0.169M |